| Literature DB >> 29401558 |
Jihye Ha1, Sung Kuk Hong2, Geum Hee Han1, Myungsook Kim1, Dongeun Yong3, Kyungwon Lee1.
Abstract
BACKGROUND: Early and appropriate antibiotic treatment improves the clinical outcome of patients with septicemia; therefore, reducing the turn-around time for identification (ID) and antimicrobial susceptibility test (AST) results is essential. We established a method for rapid ID and AST using short-term incubation of positive blood culture broth samples on solid media, and evaluated its performance relative to that of the conventional method using two rapid ID systems and a rapid AST method.Entities:
Keywords: Antimicrobial susceptibility testing; Blood culture; MALDI-TOF-MS; Rapid identification; Septicemia
Mesh:
Substances:
Year: 2018 PMID: 29401558 PMCID: PMC5820068 DOI: 10.3343/alm.2018.38.3.235
Source DB: PubMed Journal: Ann Lab Med ISSN: 2234-3806 Impact factor: 3.464
Fig. 1Workflow of rapid and conventional species identification (ID) and antimicrobial susceptibility test (AST).
Results obtained by the two MALDI-TOF MS systems using the short-term bacterial incubation method compared with those of the conventional method
| Microorganism | N | N (%) identified in MicroFlex | N (%) identified in Vitek-MS | ||||
|---|---|---|---|---|---|---|---|
| Concordance level | Non-reliable ID | Concordance level | Non-reliable ID | ||||
| Species | Genus | Species | Genus | ||||
| Gram-positive bacteria | 143 | 110 (76.9) | 116 (81.1) | 28 (19.6) | 105 (73.4) | 110 (76.9) | 33 (23.1) |
| Gram-positive cocci | 120 | 100 (83.3) | 106 (88.3) | 15 (12.5) | 96 (80.0) | 101 (84.2) | 19 (15.8) |
| | 14 | 14 (100) | 14 (100) | 0 (0.0) | 14 (100) | 14 (100) | 0 (0.0) |
| Coagulase-negative staphylococci* | 60 | 52 (86.7) | 53 (88.3) | 7 (11.7) | 47 (78.3) | 48 (80.0) | 11 (18.3) |
| Enterococci | 25 | 24 (96.0) | 24 (96.0) | 1 (4.0) | 24 (96.0) | 24 (96.0) | 1 (4.0) |
| | 12 | 12 (100) | 12 (100) | 0 (0.0) | 12 (100) | 12 (100) | 0 (0.0) |
| | 13 | 12 (92.3) | 12 (92.3) | 1 (7.6) | 12 (92.3) | 12 (92.3) | 1 (7.6) |
| Streptococci† | 19 | 10 (52.6) | 14 (73.7) | 7 (36.8) | 11 (57.9) | 14 (73.7) | 6 (31.6) |
| Other‡ | 2 | 1 (50.0) | 1 (50.0) | 1 (50.0) | 1 (50.0) | 1 (50.0) | 1 (50.0) |
| Gram-positive rods§ | 23 | 10 (43.5) | 10 (43.5) | 13 (56.5) | 9 (39.1) | 9 (39.1) | 14 (60.9) |
| Gram-negative bacteria | 111 | 99 (89.2) | 106 (95.5) | 5 (4.5) | 94 (84.7) | 100 (90.9) | 11 (9.9) |
| Enterobacteriaceae | 94 | 85 (90.4) | 90 (95.7) | 4 (4.3) | 79 (84.0) | 85 (90.4) | 9 (9.6) |
| | 53 | 52 (98.1) | 52 (98.1) | 1 (1.9) | 51 (96.2) | 51 (96.2) | 2 (3.8) |
| | 22 | 20 (90.9) | 20 (90.9) | 2 (9.1) | 17 (77.3) | 17 (77.3) | 5 (22.7) |
| Other Enterobacteriaceae∥ | 19 | 13 (68.4) | 18 (94.7) | 1 (5.3) | 11 (57.8) | 17 (89.4) | 2 (10.5) |
| Glucose non-fermenters¶ | 11 | 9 (81.8) | 10 (90.9) | 1 (9.1) | 10 (90.9) | 10 (90.9) | 1 (9.1) |
| Other Gram-negative bacteria** | 6 | 5 (83.3) | 6 (100) | 0 (0.0) | 5 (83.3) | 5 (83.3) | 1 (16.7) |
| Total | 254 | 209 (82.3) | 222 (87.4) | 33 (13.0) | 199 (78.3) | 210 (86.6) | 44 (17.3) |
*Coagulase-negative staphylococci: S. epidermidis, S. hominis, S. haemolyticus, S. capitis, S. auricularis, S. saprophyticus, S. warne.r; †Streptococci: S. pyogenes, S. agalactiae, S. anginosus, S. constellatus, S. intermedius, S. salivarius, S. pluranimalium, S. equisimilis, S. pneumoniae, S. mitis, S. parasanguinis, S. sanguis; ‡Other: Granulicatella adiacens; §Gram-positive rods: Bacillus spp., diphtheroids, Clostridium septicum, Arthrobacter spp., Listeria monocytogenes; ∥Other Enterobacteriaceae: Enterobacter cloacae, Enterobacter asburiae, Enterobacter aerogenes, Citrobacter freundii, Citrobacter braakii, Morganella morganii, Salmonella spp., Proteus mirabilis; ¶Glucose non-fermenters: Acinetobacter baumannii, Acinetobacter lwoffii, Acinetobacter radioresistens, Pseudomonas aeruginosa, Stenotrophomonas maltophilia; **Other Gram-negative bacteria: Burkholderia cepacia, Aeromonas caviae, Bacteroides caccae, Myroides spp., Ochrobactrum anthropic.
Antimicrobial susceptibility test results for the short-term incubation method compared with those of the conventional method
| Microorganism (N of ASTs conducted) | N (%) of | |||
|---|---|---|---|---|
| Agreement | Minor error | Major error | Very major error | |
| Gram-positive bacteria (517) | 509 (98.5) | 3 (0.6) | 3 (0.6) | 2 (0.4) |
| Staphylococci (368) | 364 (98.9) | |||
| | 80 (100) | |||
| | 126 (98.4) | One with teicoplanin, one with ciprofloxacin | ||
| | 94 (97.9) | One with cotrimoxazole | One with cotrimoxazole | |
| | 16 (100) | |||
| | 32 (100) | |||
| | 16 (100) | |||
| Enterococci (806) | 785 (97.4) | |||
| | 64 (98.5) | One with nitrofurantoin | ||
| | 81 (96.4) | One with penicillin G, one with gentamicin | One with vancomycin | |
| Gram-negative bacteria (657) | 639 (97.3) | 9 (1.4) | 5 (0.8) | 4 (0.6) |
| Enterobacteriaceae (608) | 590 (97.0) | |||
| | 275 (95.5) | Five with cefepime, one with ampicillin-sulbactam, one with meropenem | One with ampicillin-sulbactam, one with gentamicin, one with cotrimoxazole, one with aztreonam | One with ceftazidime, one with ertapenem |
| | 159 (99.4) | One with aztreonam | ||
| | 109 (100) | Two with ertapenem | One with meropenem | |
| | 16 (100) | |||
| | 16 (100) | |||
| | 15 (93.8) | One with amikacin | ||
| Glucose non-fermenters (49) | 49 (100) | |||
| | 16 (100) | |||
| | 17 (100) | |||
| | 16 (100) | |||
| Total (1,174) | 1,148 (97.8) | 12 (1.0) | 8 (0.7) | 6 (0.5) |
Abbreviation: AST, antimicrobial susceptibility test.